Anti-TNF11/ ODF/ TNFSF11 monoclonal antibody
Anti-TNF11/ ODF/ TNFSF11 antibody for FACS & in-vivo assay
Go to ODF/TNFSF11 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-T21334-Ab-1/ GM-Tg-hg-T21334-Ab-2 | Anti-Human ODF/TNFSF11 monoclonal antibody | Human |
GM-Tg-rg-T21334-Ab-1/ GM-Tg-rg-T21334-Ab-2 | Anti-Rat ODF/TNFSF11 monoclonal antibody | Rat |
GM-Tg-mg-T21334-Ab-1/ GM-Tg-mg-T21334-Ab-2 | Anti-Mouse ODF/TNFSF11 monoclonal antibody | Mouse |
GM-Tg-cynog-T21334-Ab-1/ GM-Tg-cynog-T21334-Ab-2 | Anti-Cynomolgus/ Rhesus macaque ODF/TNFSF11 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-T21334-Ab-1/ GM-Tg-felg-T21334-Ab-2 | Anti-Feline ODF/TNFSF11 monoclonal antibody | Feline |
GM-Tg-cang-T21334-Ab-1/ GM-Tg-cang-T21334-Ab-2 | Anti-Canine ODF/TNFSF11 monoclonal antibody | Canine |
GM-Tg-bovg-T21334-Ab-1/ GM-Tg-bovg-T21334-Ab-2 | Anti-Bovine ODF/TNFSF11 monoclonal antibody | Bovine |
GM-Tg-equg-T21334-Ab-1/ GM-Tg-equg-T21334-Ab-2 | Anti-Equine ODF/TNFSF11 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-T21334-Ab-1/ GM-Tg-hg-T21334-Ab-2; GM-Tg-rg-T21334-Ab-1/ GM-Tg-rg-T21334-Ab-2; GM-Tg-mg-T21334-Ab-1/ GM-Tg-mg-T21334-Ab-2; GM-Tg-cynog-T21334-Ab-1/ GM-Tg-cynog-T21334-Ab-2; GM-Tg-felg-T21334-Ab-1/ GM-Tg-felg-T21334-Ab-2; GM-Tg-cang-T21334-Ab-1/ GM-Tg-cang-T21334-Ab-2; GM-Tg-bovg-T21334-Ab-1/ GM-Tg-bovg-T21334-Ab-2; GM-Tg-equg-T21334-Ab-1/ GM-Tg-equg-T21334-Ab-2 |
Products Name | Anti-ODF/TNFSF11 monoclonal antibody |
Format | mab |
Target Name | ODF |
Protein Sub-location | Transmembrane Protein |
Category of antibody | FACS/Biofunctional Antibody, Therapeutics Target antibody, Cytokine antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD). |
Tag | Fc |
Products description | Pre-made anti-ODF benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Biosimilar | GMP-Bios-ab-140 | Pre-Made Denosumab biosimilar, Whole mAb, Anti-TNFSF11/ODF Antibody: Anti-OPGL/sCD254/OPTB2/RANKL/TNLG6B/TRANCE/hRANKL2 therapeutic antibody |
Target Antigen | Products Developing | Multi-species TNF11/ ODF/ TNFSF11 VLP (virus-like particle) (Products Developing) |
Cytokine | GM-Tg-g-T21334-Ag-1 | tumor necrosis factor (ligand) superfamily, member 11 (TNFSF11) protein |
ORF Viral Vector | vGMLP001907 | human TNFSF11 Lentivirus particle |
ORF Viral Vector | pGMLP001907 | human TNFSF11 Lentivirus plasmid |
ORF Viral Vector | pGMAAV000113 | mouse Tnfsf11 AAV plasmid |
ORF Viral Vector | vGMAAV000113 | mouse Tnfsf11 AAV particle |
Target information
Target ID | GM-T21334 |
Target Name | ODF |
Gene ID | 8600,21943,117516,699955,609418,724036,513836,100060254 |
Gene Symbol and Synonyms | CD254,hRANKL2,Ly109l,ODF,OPGL,OPTB2,RANKL,sOdf,TNFSF11,TNLG6B,TRANCE |
Uniprot Accession | O14788,Q9ESE2 |
Uniprot Entry Name | TNF11_HUMAN,TNF11_RAT |
Protein Sub-location | Transmembrane Protein |
Category | Therapeutics Target, Immuno-oncology Target, INN Index, Cytokine Target |
Disease | Cancer |
Gene Ensembl | ENSG00000120659 |
Target Classification | Checkpoint-Immuno Oncology, Tumor-associated antigen (TAA) |
The target: ODF, gene name: TNFSF11, also named as CD254, ODF, OPGL, OPTB2, RANKL, TNLG6B, TRANCE, hRANKL2, sOdf. This gene encodes a member of the tumor necrosis factor (TNF) cytokine family which is a ligand for osteoprotegerin and functions as a key factor for osteoclast differentiation and activation. This protein was shown to be a dentritic cell survival factor and is involved in the regulation of T cell-dependent immune response. T cell activation was reported to induce expression of this gene and lead to an increase of osteoclastogenesis and bone loss. This protein was shown to activate antiapoptotic kinase AKT/PKB through a signaling complex involving SRC kinase and tumor necrosis factor receptor-associated factor (TRAF) 6, which indicated this protein may have a role in the regulation of cell apoptosis. Targeted disruption of the related gene in mice led to severe osteopetrosis and a lack of osteoclasts. The deficient mice exhibited defects in early differentiation of T and B lymphocytes, and failed to form lobulo-alveolar mammary structures during pregnancy. Two alternatively spliced transcript variants have been found. [provided by RefSeq, Jul 2008].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.